date/time interval
- September 1, 2024 - August 31, 2027
Targeting ecDNA to reverse therapy-resistance in urothelial cancer.
Grant
Overview
awarded by
administered by
sponsor award ID
- HT9425-24-1-0798
Affiliation
contributor
- Faltas, Bishoy Morris Key Personnel 2024 - 2027